Breaking News Bar

Business News and Information

MedImmune announces $250 million spinout, plan to create 100 new jobs

The new company will focus on drug development for inflammatory and autoimmune diseases — and could be filing for its first drug product by the end of this decade.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear